The genome e-volution (Volume 12)

"We have made great progress, but we are still vulnerable and our common commitment to fight global health challenges is not yet strong enough. Despite our knowledge, despite new technologies, without concentrated and global efforts we are limited in our success. Today we see it clearly."...

Full description

Saved in:
Bibliographic Details
Main Author: Đikić, Ivan (auth)
Other Authors: Investment Bank, European (Editor)
Format: Book Chapter
Published: 2020
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02368naaaa2200301uu 4500
001 doab_20_500_12854_28167
005 20210210
020 |a /doi.org/10.2867/7 
024 7 |a https://doi.org/10.2867/7  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a KFF  |2 bicssc 
100 1 |a Đikić, Ivan  |4 auth 
700 1 |a Investment Bank, European  |4 edt 
700 1 |a Investment Bank, European  |4 oth 
245 1 0 |a The genome e-volution (Volume 12) 
260 |c 2020 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a "We have made great progress, but we are still vulnerable and our common commitment to fight global health challenges is not yet strong enough. Despite our knowledge, despite new technologies, without concentrated and global efforts we are limited in our success. Today we see it clearly." The sequencing of the human genome at the beginning of this millennium marked a new era in biomedicine. Nanotechnology and robotics have created innovative tools and powerful diagnostic techniques. Major therapeutic advances have enabled us to control HIV, and more tailor-made therapies are being implemented to treat cancer. Nonetheless huge challenges remain, not only in the field of cancer, but also with respect to neurodegenerative and other diseases. At the same time, international travel and mobility, as well as globalised trade, are affecting our living conditions and promoting the spread of infectious diseases and new viruses, like the COVID-19 coronavirus, all over the world. The Croatian physician and scientist Ivan Đikić analyses the challenges of contemporary medical research, the emerging threats, like pandemics, and the role played by health systems. This is the twelfth essay in the Big Ideas series created by the European Investment Bank. 
536 |a Knowledge Unlatched 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode 
546 |a English 
650 7 |a Finance  |2 bicssc 
653 |a Business & Economics 
653 |a Finance 
653 |a General 
856 4 0 |a www.oapen.org  |u https://library.oapen.org/bitstream/20.500.12657/43393/1/external_content.epub  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/28167  |7 0  |z DOAB: description of the publication